The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase

EMBO Journal

Volumn 14, Issue 22, 1995, Pages 5618-5625

  Baeg, Gyeong Hun ^a   Matsumine, Akihiko ^a   Kuroda, Toshihiko ^b   Bhattacharjee, Rabindra Nath ^a   Miyashiro, Isao ^a,c   Toyoshima, Kumao ^a,d   Akiyama, Tetsu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d CENTER FOR ADULT DISEASES   (Japan)

Author keywords

APC; CDK; Cell cycle; Cyclin; Tumour suppressor gene

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; CYTOPLASM PROTEIN; GENE PRODUCT; MUTANT PROTEIN;

ADENOMATOUS POLYP; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FAMILIAL CANCER; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0028801360     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1995.tb00249.x     Document Type: Article

References (58)

1. Akiyama,T., Ohuchi,T., Sumida,S., Matsumoto,K. and Toyoshima,K. (1992) Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl Acad. Sci. USA, 89, 7900-7904.
2. Bodmer,W.F. et al. (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature, 328, 614-616.
3. Burt,R. and Samowitz,W. (1988) The adenomatous polyp and the hereditary polyposis syndromes. Gastroenterol. Clin. North Am., 17, 657-678.
4. Cross,S.M., Sanchez,C.A., Morgan,C.A., Schimke,M.K., Ramel,S., Idzerda,R.L., Raskind,W.H. and Reid,B.J. (1995) A p53-dependent mouse spindle checkpoint. Science, 267, 1353-1356.
5. Dowdy,S.F., Hinds,P.W., Louie,K., Reed,S.I., Arnold,A. and Weinberg,R.A. (1993) Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73, 499-511.
6. El-Deiry,W.S. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
7. Ewen,M.E., Sluss,H.K., Sherr,C.J., Matsushime,H., Kato,J. and Livingston,D.M. (1993a) Functional interaction of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
8. Ewen,M.E., Sluss,H.K., Whitehouse,L.L. and Livingston,D.M. (1993b) TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74, 1009-1020.
9. Fearon,E. and Vogelstein,B. (1990) Genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
10. Fodde,R. et al. (1994) A targeted chain-termination mutation in the mouse APC gene results in multiple intestinal tumors. Proc. Natl Acad. Sci. USA, 91, 8969-8973.
11. Gardner,E.J. and Richards,R.C. (1953) Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am. J. Hum. Genet., 5, 139-148.
12. Geng,Y. and Weinberg,R.A. (1993) Transforming growth factor b effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl Acad. Sci. USA. 90, 10315-10319.
13. Gossen,M. and Bujard,H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
14. Groden,J. et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66, 589-600.
15. Groden,J. et al. (1993) Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am. J. Hum. Genet., 52, 263-272.
16. Gu,Y, Turck,C.W. and Morgan,D.O. (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature, 366, 707-710.
17. Hamaguchi,M., Matsuyoshi,N., Ohnishi,Y., Gotoh,B., Takeichi,M. and Nagai,Y. (1993) p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion EMBO J., 12, 307-314.
18. Hannon,G.J. and Beach,D. (1994) p15 is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.
19. Harper,J.W., Adami,G.R., Wei,N., Keyomarsi,K. and Elledge,S. (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
20. Herrera,L. (1990) Familial Adenomatous Polyposis. Alan R.Liss, Inc., New York.
21. Hinds,P.W., Mittnacht,S., Dulic,V, Arnold,A., Reed,S.I. and Weinberg,R.A. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70, 993-1006.
22. Hunter,T. (1993) Braking the cycle. Cell, 75, 839-841.
23. Hunter,T. and Pines,J. (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
24. Inoue,N., Kinoshita,T., Orii,T. and Takeda,J. (1993) Cloning of a human gene, PIG-F, a component of glycosylphosphatidylinositol anchor biosynthesis, by a novel expression cloning strategy. J. Biol. Chem. 268, 6882-6885.
25. Joslyn,G. et al. (1991) Identification of deletion mutations and three new genes at the familial polyposis locus. Cell, 66, 601-613.
26. Joslyn.G., Richardson,D.S., White.R. and Alber.T. (1993) Dimer formation by an N-terminal coiled coil I the APC protein. Proc Natl Acad. Sci. USA. 90, 11109-11113.
27. Karantza,V., Maroo,A., Fay,D. and Sedivy,J.M. (1993) Overproduction of Rb protein after the G1/S boundary causes G2 arrest. Mol Cell, Biol., 13, 6640-6652.
28. Kato,J.-Y, Matsushime,H., Hiebert,S.W., Ewen,M.E. and Sherr,C.J. (1993) Direct binding of cyclin D to the retinoblastoma gene product and pRB phosphorylation by the cyclin D-dependent kinase, cdk4 Genes Dev., 7, 331-342.
29. Kinzler,K.W. et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science, 253, 661-665.
30. Kudoh,T., Ishidate,T., Moriyama,M., Toyoshima,K. and Akiyama,T. (1995) G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyc]in/CDK complexes. Proc. Nat! Acad. Sci. USA 91 4517-4521.
31. Kunkel,T.A. (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA, 82, 488-492.
32. Leppert,M. et al. (1987) The gene for familial polyposis coli maps to the long arm of chromosome 5. Science, 238, 1411-1413.
33. Marshall,C.J. (1994) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinasc activation. Cell, 80, 179-185.
34. Matsushime,H., Quelle,D.E., Shurtleff,S.A., Shibuya,M., Sherr,CJ. and I Kato,J.-Y (1994) D-type cyclin-dependent kinase activity in I mammalian cells. Mol Cell Biol., 14, 2066-2076.
35. J Miyoshi,Y. et al. (1992a) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. Natl Acad. Sci. USA. 89, 4452-4456.
36. Miyoshi,Y et al. (1992b) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet., 1, 229-233.
37. Mitsunobu,F., Fukui,M., Oda,T., Yamamoto,T. and Toyoshima,K. (1989) Mechanism of c-raf-1 activation: fusion of the lipocortin II amino-terminal sequence with the c-raf-1 kinase domain. Oncogene, 4, 437-442.
38. Munemitsu,S., Souza,B., Muller,O., Albert,I., Rubinfeld,B. and Polakis, P. (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res., 15, 3676-3681.
39. Nagase,H. et al (1992) Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res., 52, 4055-4057.
40. Nishida,E. and Gotoh,Y (1993) The MAP kinase cascade is essental for diverse signal transduction pathways. Trends Biochem. Sci., 18, 128-131.
41. Nishisho,I. et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-669.
42. Noda,A., Ning,Y., Venable,S.F., Pereira-Smith,O.M. and Smith,J.R (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res., 211, 90-98.
43. Olschwang,S., Laurent-Puig,P., Groden,J., White,R. and Thomas. (1993) Germline mutations in the first fourteen exons of the AP gene. Am. J. Hum. Genet., 52, 273-279.
44. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibiton to cell cycle arrest. Genes. Dev 8, 9-22.
45. Kip1, a cycb dependent kinase inhibitor and a potential mediator of extracell antimitogenic signals. Cell, 78, 59-66.
46. Powell,S.M., Nilz,N., Beazer-Barclay,Y., Bryan,T.M., Hamiltun,S.R., Thibodeau,S.N., Vogelstein,B. and Kinzler,K.W. (1992) APC mistasus occur early during colorectal tumorigenesis. Nature, 359, 235-237.
47. Rubinfeld,B., Souza,B., Albert,I., Muller,O., Chamberian,S.R., Masiarz,F.R., Munemitsu,S. and Polakis,P. (1993) Association of the APC gene product with β-catenin. Science, 262, 1731-1734.
48. Sherr,C.J. (1994) G1 phase progression: cycling on cue. Cell, 79, 551-555.
49. Shibata,T., Gotoh,M., Ochiai,A. and Hirohashi,S. (1994) Association of plakoglabion with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation. Biochem. Biophys. Res. Commun., 203, 519-522.
50. Smith,K.J., et al. (1993) The APC gene product in normal and tumor Cells. Proc. Natl Acad. Sci USA, 90, 2846-2850.
51. Smith,K.J., Levy,D.B., Maupin,P., Pollard,T.D., Vogelstein,B. and Kinzle,K.W. (1994) Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res., 15, 3672-3675.
52. Su,L.-K., Kinzler,K.W., Vogelstein,B., Preisinger,A.C., Mosner,A.R., Luongo,C., Gould,K.A. and Dove,W.F. (1992) Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC gene. Science, 256, 668-671.
53. Su,L.-K., Johnson,K.A., Smith,K.J., Hill,D.E., Vogelstein,B. and Kinzle,K. (1993a) Association between wild type and mutant APC gene products. Cancer Res., 53, 2728-2731.
54. Su,L-K., Vogelstein,B. and Kinzler,K.W. (1993b) Association of the APC tumor suppressor protein with catenins. Science, 262, 1734-1737.
55. Toyoshima,H. and Hunter,T. (1994) p27, a novel inhibitor of G1 cyclin-C4k protein kinase activity, is related to p21. Cell, 78, 67-74.
56. Varesco,L. et al. (1993) Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis. Am. J. Hum. Genet., 52, 280-285.
57. Vegelstein,B. and Kinzler,K.W. (1993) The multistep nature of cancer. Trends Genet., 9, 138-141.
58. Xiong,Y., Hannon,G.J., Zhang,H., Casso,D., Kobayashi,R. and Beach,D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.